Newshot Domestic Fully Femtosecond Equipment Enters Clinical Trial Stage, Future Myopia Surgery Expected to Drop in Price
IT Home, November 13 news, according to a report by CCTV Finance today, for a long time, domestic myopia surgery has mostly relied on imported equipment, and patients undergoing surgery have to pay a "startup fee," making the comprehensive treatment cost very high.
Now, domestic fully femtosecond equipment has entered the clinical trial stage. In the future, the price of femtosecond surgery will become more affordable.
According to another message from "Xianju Release," the first domestic femtosecond laser corneal refractive treatment machine has entered the clinical trial stage and is expected to complete clinical trials and officially go on the market in June next year.
The domestic equipment requires only about 9 seconds for a single-eye laser scan, and its cutting precision can reach the international advanced level. It is expected to break the monopoly of imported equipment, eliminate related hidden costs, and make myopia correction more affordable.
Data from the National Health Commission shows that China has more than 600 million people with myopia. Fully femtosecond laser surgery can use a fully femtosecond refractive correction device to cut out and remove a micro-lens within the corneal stroma, thereby changing the corneal curvature and correcting vision. It is safer than procedures such as half-femtosecond surgery. A fully femtosecond laser surgery usually costs around 20,000 yuan. But currently, only a few companies worldwide, such as Zeiss, produce fully femtosecond refractive correction devices.
IT Home noted that the Optics Valley Media Center published an article last December stating that the first domestic femtosecond laser corneal refractive treatment machine (referred to as the "fully femtosecond refractive correction device") and its onboard ultrafast fiber laser were developed by Andun Medical and Anyang Laser, respectively. R&D personnel from these two upstream and downstream medical device companies frequently visit each other to exchange ideas, working together to achieve full domesticization of fully femtosecond laser surgery from components to equipment.
Wu Ke, Clinical Director of Andun Medical, said: "After the instrument goes on the market, its price is expected to be 50% lower than that of foreign products, which is expected to drive a significant reduction in the cost of fully femtosecond laser surgery and benefit more patients."
Advertising Statement: The external jump links contained in the article (including but not limited to hyperlinks, QR codes, passwords, etc.) are used to convey more information and save selection time. The results are for reference only, and all articles on IT Home containing external links include this statement.
Related Articles
- Global foldable phone market bucks the trend and surges, Counterpoint estimates global panel shipments will soar more than 23% year-on-year in 2026
- Letting AI perform brain surgery itself, startup successfully has agent treat epilepsy in mice
- Chinese researchers successfully use new minimally invasive surgery to treat heart failure patients: no chest opening, heart keeps beating, patients can get out of bed in one or two days
- Xiaomi announces 21-DOF bionic dexterous hand: 26 motors with hybrid drive, 1500-point high-density full-palm touch sensing
- China's surgical robot exports reached 672 million yuan in the first 8 months of this year, up 272.92% year-on-year, with Guangdong and Shanghai leading the country
- Chinese-Russian team completes "world's first" spinal cord transplant surgery, patient in good condition postoperatively